Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Clinical Thyroidology / Original Paper

Free Access

Relational Stability of Thyroid Hormones in Euthyroid Subjects and Patients with Autoimmune Thyroid Disease

Hoermann R.a · Midgley J.E.M.b · Larisch R.a · Dietrich J.W.c, d

Author affiliations

aDepartment of Nuclear Medicine, Klinikum Luedenscheid, Luedenscheid, Germany; bNorth Lakes Clinical, Ilkley, UK; cMedical Department I, Endocrinology and Diabetology, Bergmannsheil University Hospitals, Ruhr University of Bochum, and dRuhr Center for Rare Diseases (CeSER), Ruhr University of Bochum and Witten/Herdecke University, Bochum, Germany

Corresponding Author

Prof. Dr. Rudolf Hoermann

Department of Nuclear Medicine, Klinikum Luedenscheid

Paulmannshoeher Strasse 14

DE-58515 Luedenscheid (Germany)

E-Mail rudolf.hoermann@gmail.com

Related Articles for ""

Eur Thyroid J 2016;5:171-179

Do you have an account?

Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



Abstract

Background/Aim: Operating far from its equilibrium resting point, the thyroid gland requires stimulation via feedback-controlled pituitary thyrotropin (TSH) secretion to maintain adequate hormone supply. We explored and defined variations in the expression of control mechanisms and physiological responses across the euthyroid reference range. Methods: We analyzed the relational equilibria between thyroid parameters defining thyroid production and thyroid conversion in a group of 271 thyroid-healthy subjects and 86 untreated patients with thyroid autoimmune disease. Results: In the euthyroid controls, the FT3-FT4 (free triiodothyronine-free thyroxine) ratio was strongly associated with the FT4-TSH ratio (tau = -0.22, p < 0.001, even after correcting for spurious correlation), linking T4 to T3 conversion with TSH-standardized T4 production. Using a homeostatic model, we estimated both global deiodinase activity and maximum thyroid capacity. Both parameters were nonlinearly and inversely associated, trending in opposite directions across the euthyroid reference range. Within the panel of controls, the subgroup with a relatively lower thyroid capacity (<2.5 pmol/s) displayed lower FT4 levels, but maintained FT3 at the same concentrations as patients with higher functional and anatomical capacity. The relationships were preserved when extended to the subclinical range in the diseased sample. Conclusion: The euthyroid panel does not follow a homogeneous pattern to produce random variation among thyroid hormones and TSH, but forms a heterogeneous group that progressively displays distinctly different levels of homeostatic control across the euthyroid range. This suggests a concept of relational stability with implications for definition of euthyroidism and disease classification.

© 2016 European Thyroid Association Published by S. Karger AG, Basel


References

  1. Hoermann R, Midgley JEM, Larisch R, Dietrich JW: Homeostatic control of the thyroid-pituitary axis: perspectives for diagnosis and treatment. Front Endocrinol 2015;6:1-17.
  2. Pilo A, Iervasi G, Vitek F, Ferdeghini M, Cazzuola F, Bianchi R: Thyroidal and peripheral production of 3,5,3′-triiodothyronine in humans by multicompartmental analysis. Am J Physiol Endocrinol Metab 1990;258:E715-E726.
    External Resources
  3. Visser WE, Friesema ECH, Visser TJ: Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol Endocrinol 2011;25:1-14.
  4. Hoermann R, Midgley JEM, Giacobino A, Eckl WA, Wahl HG, Dietrich JW, Larisch R: Homeostatic equilibria between free thyroid hormones and pituitary thyrotropin are modulated by various influences including age, body mass index and treatment. Clin Endocrinol (Oxf) 2014;81:907-915.
  5. Larisch R, Giacobino A, Eckl WA, Wahl HG, Midgley JEM, Hoermann R: Reference range for thyrotropin. Post hoc assessment. Nuklearmedizin 2015;54:112-117.
  6. Dietrich JW, Landgrafe G, Fotiadou EH: TSH and thyrotropic agonists: key actors in thyroid homeostasis. J Thyroid Res 2012;2012:1-29.
  7. Dietrich JW, Tesche A, Pickardt CR: Thyrotropic feedback control: evidence for an additional ultrashort feedback loop from fractal analysis. Cybern Syst 2004;35:315-331.
    External Resources
  8. Dietrich JW, Landgrafe-Mende G, Wiora E, Chatzitomaris A, Klein HH, Midgley JEM, Hoermann R: Calculated parameters of thyroid homeostasis: emerging tools for differential diagnosis and clinical research. Front Endocrinol 2016;7:57.
  9. Hoermann R, Midgley JEM, Larisch R, Dietrich JW: Is pituitary TSH an adequate measure of thyroid hormone-controlled homoeostasis during thyroxine treatment? Eur J Endocrinol 2013;168:271-280.
  10. Dietrich JW: Der Hypophysen-Schilddrüsen-Regelkreis. Berlin, Logos, 2002.
  11. Dietrich JW, Stachon A, Antic B, Klein HH, Hering S: The AQUA-FONTIS Study: protocol of a multidisciplinary, cross-sectional and prospective longitudinal study for developing standardized diagnostics and classification of non-thyroidal illness syndrome. BMC Endocr Disord 2008;8:13.
  12. R Core Team: R: a Language and Environment for Statistical Computing. R Foundation for Statistical Computing 2015. http://www.R-project.org/.
  13. Fellows I: Deducer: a data analysis GUI for R. J Stat Soft 2012;49:1-15.
  14. Revelle W: psych, Version 1.5.8 2015: procedures for personality and psychological research. Evanston, Northwestern University. http://CRAN.R-project.org/package=psych.
  15. Baloch ZW, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Nicoli-Sire P, Rhys J, Rut J, Smyth PPA, Spencer CA, Stockight JR: Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3-126.
  16. Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RB, Rosenthal MS, Sawka AM: Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid 2014;24:1670-1751.
  17. Hoermann R, Midgley JEM, Larisch R, Dietrich JW: Integration of peripheral and glandular regulation of triiodothyronine production by thyrotropin in untreated and thyroxine-treated subjects. Horm Metab Res 2015;47:674-680.
  18. Gullo D, Latina A, Frasca F, Le Moli R, Pellegriti G, Vigneri R: Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PLoS One 2011;6:e22552.
  19. Ito M, Miyauchi A, Morita S, Kudo T, Nishihara E, Kihara M, Takamura Y, Ito Y, Kobayashi K, Miya A, Kubota S, Amino N: TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy. Eur J Endocrinol 2012;167:373-378.
  20. Ito M, Miyauchi A, Kang S, Hisakado M, Yoshioka W, Ide A, Kudo T, Nishihara E, Kahara M, Ito Y, Kobayashi K, Miya A, Fukata S, Nakamura H, Amino N: Effect of the presence of remnant thyroid tissue on the serum thyroid hormone balance in thyroidectomized patients. Eur J Endocrinol 2015;173:1-178.
  21. Dickey RA, Wartofsky L, Feld S: Optimal thyrotropin level: normal ranges and reference intervals are not equivalent. Thyroid 2005;15:1035-1039.
  22. Wartofsky L, Dickey RA: The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005;90:5483-5488.
  23. Brabant G, Beck-Peccoz P, Jarzab B, Laurberg P, Orgiazzi J, Szabolcs I, Weetman AP, Wieringa WM: Is there a need to redefine the upper normal limit of TSH? Eur J Endocrinol 2006;154:633-637.
  24. Laurberg P, Andersen S, Carlé A, Karmisholt J, Knudsen N, Pedersen IB: The TSH upper reference limit: where are we at? Nat Rev Endocrinol 2011;7:232-239.
  25. Panicker V, Cluett C, Shields B, Murray A, Parnell KS, Perry JRB, Weedon MN, Singleton A, Hernandez D, Evans J, Durant C, Ferrucci L, Melzer D, Saravanan P, Visser TJ, Ceresini G, Hattersley AT, Vaisya B, Dayan CM, Frayling TM: A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. J Clin Endocrinol Metab 2008;93:3075-3081.
  26. Taylor PN, Panicker V, Sayers A, Shields B, Iqbal A, Bremner AP, Beilby JP, Leedman PJ, Hattersley AT, Vaisya B, Frayling T, Evans J, Tobias JH, Timpson NJ, Walsh JP, Dayan CM: A meta-analysis of the associations between common variation in the PDE8B gene and thyroid hormone parameters, including assessment of longitudinal stability of associations over time and effect of thyroid hormone replacement. Eur J Endocrinol 2011;164:773-780.
  27. Hoftijzer HC, Heemstra KA, Visser TJ, le Cessie S, Peeters RP, Corssmit EPM, et al: The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma. J Clin Endocrinol Metab 2011;96: E1527-E1533.
  28. McAninch EA, Jo S, Preite NZ, Farkas E, Mohácsik P, Fekete C, Egri P, Gereben B, Li Y, Deng Y, Patti ME, Zevenbergen C, Peeters RP, Mash DC, Bianco AC: Prevalent polymorphism in thyroid hormone-activating enzyme leaves a genetic fingerprint that underlies associated clinical syndromes. J Clin Endocrinol Metab 2015;100:920-933.
  29. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR: Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002;23:38-89.
  30. Gereben B, McAninch EA, Ribeiro MO, Bianco AC: Scope and limitations of iodothyronine deiodinases in hypothyroidism. Nat Rev Endocrinol 2015;11:642-652.
  31. Fonseca TL, Correa-Medina M, Campos MPO, Wittmann G, Werneck-de-Castro JP, Arrojo e Drigo R, Mora-Garzon M, Ueta CB, Caicedo A, Fekete C, Gereben B, Lechan RM, Bianco AC: Coordination of hypothalamic and pituitary T3 production regulates TSH expression. J Clin Invest 2013;123:1492-1500.
  32. Werneck de Castro JP, Fonseca TL, Ueta CB, McAninch EA, Abdalla SM, Wittmann G, Lechan RM, Gerber B, Bianco AC: Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine. J Clin Invest 2015;125:769-781.
  33. Andersen S, Bruun NH, Pedersen KM, Laurberg P: Biologic variation is important for interpretation of thyroid function tests. Thyroid 2003;13:1069-1078.
  34. Ehrenkranz J, Bach PR, Snow GL, Schneider A, Lee JL, Ilstrup S, Bennet ST, Benvenga S: Circadian and circannual rhythms in thyroid hormones: determining the TSH and free T4 reference intervals based upon time of day, age, and sex. Thyroid 2015;25:954-961.
  35. Russell W, Harrison RF, Smith N, Darzy K, Shalet S, Weetman AP, Ross RJ: Free triiodothyronine has a distinct circadian rhythm that is delayed but parallels thyrotropin levels. J Clin Endocrinol Metab 2008;93:2300-2306.
  36. Spencer CA, Hollowell JG, Kazarosyan M, Braverman LE: National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab 2007;92:4236-4240.
  37. Hamilton TE, Davis S, Onstad L, Kopecky KJ: Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. J Clin Endocrinol Metab 2008;93:1224-1230.
  38. Hoermann R, Larisch R, Dietrich JW, Midgley JEM: Derivation of a multivariate reference range for pituitary thyrotropin and thyroid hormones: diagnostic efficiency compared to conventional single reference method. Eur J Endocrinol 2016;174:735-743.

Article / Publication Details

Received: March 17, 2016
Accepted: June 21, 2016
Published online: August 18, 2016
Issue release date: September 2016

Number of Print Pages: 9
Number of Figures: 3
Number of Tables: 2

ISSN: 2235-0640 (Print)
eISSN: 2235-0802 (Online)

For additional information: https://www.karger.com/ETJ


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.